Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Atara Biotherapeutics (AT20) vs. Competitors

0 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:AT20Atara BiotherapeuticsEUR 7.10EUR 73.27M-8.15-31.73%Moderate BuyUnlock the DE:AT20 analyst price target with TipRanks PremiumDE:AT20Unlock the DE:AT20 top-analyst price target with TipRanks Premium
MGNXMacroGenics$2.29$154.15M-10.5455.78%Moderate BuyUnlock the MGNX analyst price target with TipRanks PremiumDE:AT20 vs MGNXUnlock the MGNX top-analyst price target with TipRanks Premium
ZNTLZentalis Pharmaceuticals$1.89$176.88M-0.9835.00%Moderate BuyUnlock the ZNTL analyst price target with TipRanks PremiumDE:AT20 vs ZNTLUnlock the ZNTL top-analyst price target with TipRanks Premium
SRZNSurrozen$31.88$622.17M-0.73163.12%Strong BuyUnlock the SRZN analyst price target with TipRanks PremiumDE:AT20 vs SRZNUnlock the SRZN top-analyst price target with TipRanks Premium
TCRXTScan Therapeutics$0.19$12.55M-0.20-84.84%HoldUnlock the TCRX analyst price target with TipRanks PremiumDE:AT20 vs TCRXUnlock the TCRX top-analyst price target with TipRanks Premium

Performance Comparison

-100%0%100%200%300%400%500%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:AT20Atara Biotherapeutics7.10-3.30-31.73%
MGNXMacroGenics2.290.6943.12%
ZNTLZentalis Pharmaceuticals1.890.5743.18%
SRZNSurrozen31.8819.76163.04%
TCRXTScan Therapeutics0.18-0.94-83.63%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts